tradingkey.logo

Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing Ht-001 Oncology Trial Toward Multi-Country Site Activation

ReutersJan 15, 2026 1:19 PM

- Hoth Therapeutics Inc HOTH.O:

  • HOTH THERAPEUTICS REACHES KEY EU REGULATORY INFLECTION POINT ADVANCING HT-001 ONCOLOGY TRIAL TOWARD MULTI-COUNTRY SITE ACTIVATION

  • HOTH THERAPEUTICS : COUNTRY-SPECIFIC PART II REGULATORY DECISIONS IN HUNGARY, SPAIN, & POLAND ARE EXPECTED BY JAN 19, 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI